- cafead   Jul 31, 2023 at 10:02: PM
via Sumitomo Pharma and Otsuka Pharmaceutical announced Monday that two Phase III studies of ulotaront failed to meet primary endpoints for acutely psychotic adults living with schizophrenia.
article source
article source